CA Stock MarketDetailed Quotes

VM Voyageur Pharmaceuticals Ltd

Watchlist
  • 0.070
  • +0.005+7.69%
15min DelayMarket Closed Dec 13 16:00 ET
10.34MMarket Cap-7.00P/E (TTM)

Voyageur Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Aug 31, 2024
(Q2)May 31, 2024
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
86.80%-11.07K
60.49%-189.29K
61.39%-183.07K
42.33%-991.25K
125.17%45.91K
92.37%-83.83K
-323.22%-479.13K
-46.31%-474.2K
-4.27%-1.72M
60.29%-182.39K
Net income from continuing operations
-193.05%-357.39K
9.51%-562.4K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
71.48%-121.96K
-23.28%-621.49K
-51.08%-373.69K
14.51%-1.75M
-11.00%-574.78K
Operating gains losses
---1.24K
--6.11K
--1.25K
-119.92%-1.24K
----
----
----
----
--6.21K
----
Depreciation and amortization
-28.15%393
-28.21%392
-28.02%393
-76.28%2.19K
-92.23%546
-24.76%547
-24.90%546
-24.90%546
11.98%9.21K
-14.54%7.03K
Asset impairment expenditure
----
----
----
--48.61K
----
----
----
----
--0
----
Remuneration paid in stock
184.22%22.88K
7.80%239.55K
367.25%125.07K
12.90%234.03K
-87.39%12.22K
-124.60%-27.16K
--222.21K
--26.77K
-71.90%207.29K
589.95%96.89K
Other non cashItems
----
----
---1
-74.21%14.48K
--14.48K
----
----
----
--56.15K
----
Change In working capital
299.91%324.29K
231.33%127.05K
114.99%19.17K
145.19%110.15K
12.17%253.63K
110.36%81.09K
-124.79%-96.75K
-64.97%-127.82K
28.87%-243.73K
222.55%226.11K
-Change in receivables
-159.10%-10.47K
-43.12%-9.16K
228.36%18.08K
-168.26%-12.05K
-1,108.36%-9.29K
-44.27%17.72K
26.13%-6.4K
-120.13%-14.08K
161.14%17.65K
111.01%921
-Change in inventory
--0
--0
--0
--0
--0
--0
--0
--0
-463.10%-610
----
-Change in prepaid assets
494.81%45.98K
-4.55%46.33K
-4,816.94%-131.18K
174.84%51.12K
-60.24%16.9K
90.13%-11.65K
5,004.21%48.54K
-142.46%-2.67K
-195.72%-68.31K
187.49%42.5K
-Change in payables and accrued expense
284.94%288.78K
164.71%89.88K
219.09%132.27K
136.93%71.08K
34.21%246.02K
110.77%75.02K
-134.90%-138.89K
-43.56%-111.07K
33.83%-192.46K
187.29%183.3K
Cash from discontinued investing activities
Operating cash flow
86.80%-11.07K
60.49%-189.29K
61.39%-183.07K
42.33%-991.25K
125.17%45.91K
92.37%-83.83K
-323.22%-479.13K
-46.31%-474.2K
-4.27%-1.72M
60.29%-182.39K
Investing cash flow
Cash flow from continuing investing activities
-0.45%-54.99K
15.05%-38.1K
10.44%-37.55K
36.27%-174.72K
11.66%-33.21K
15.65%-54.74K
-291.95%-44.85K
78.51%-41.92K
37.42%-274.15K
79.73%-37.59K
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
--8.76K
--11.24K
Net other investing changes
-0.45%-54.99K
15.05%-38.1K
10.44%-37.55K
38.24%-174.72K
---33.21K
---54.74K
-291.95%-44.85K
78.23%-41.92K
35.42%-282.91K
----
Cash from discontinued investing activities
Investing cash flow
-0.45%-54.99K
15.05%-38.1K
10.44%-37.55K
36.27%-174.72K
11.66%-33.21K
15.65%-54.74K
-291.95%-44.85K
78.51%-41.92K
37.42%-274.15K
79.73%-37.59K
Financing cash flow
Cash flow from continuing financing activities
242.00%55.92K
-138.59%-9.19K
-58.80%468.28K
-6.19%1.14M
3.88%-12.5K
-98.62%16.35K
-145.79%-3.85K
3,760.51%1.14M
-58.17%1.21M
-39.06%-13.01K
Net issuance payments of debt
----
----
----
--0
----
----
----
----
12.18%-16.56K
6.29%-8.76K
Net common stock issuance
-96.76%530
-46.30%-5.63K
-58.86%493.6K
-3.70%1.2M
-194.74%-12.5K
-98.69%16.35K
---3.85K
--1.2M
-45.94%1.25M
---4.24K
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
-94.78%41K
--0
Net other financing activities
--0
---3.56K
60.09%-25.32K
-7.54%-63.45K
--0
--0
--0
---63.45K
66.47%-59K
--0
Cash from discontinued financing activities
Financing cash flow
242.00%55.92K
-138.61%-9.19K
-58.80%468.28K
-6.19%1.14M
3.88%-12.5K
-98.62%16.35K
-145.79%-3.85K
3,760.51%1.14M
-58.17%1.21M
-39.08%-13.01K
Net cash flow
Beginning cash position
-89.39%13.17K
-61.69%249.75K
-93.39%2.09K
-96.12%31.56K
-99.29%1.88K
-48.68%124.1K
101.67%651.94K
-96.12%31.56K
27,300.30%812.97K
-81.97%264.54K
Current changes in cash
91.71%-10.13K
55.18%-236.58K
-60.08%247.67K
96.23%-29.48K
100.09%203
-638.30%-122.22K
-548.18%-527.83K
226.68%620.37K
-196.47%-781.41K
64.38%-232.98K
End cash Position
61.26%3.04K
-89.39%13.17K
-61.69%249.75K
-93.39%2.09K
-93.39%2.09K
-99.29%1.88K
-48.68%124.1K
101.67%651.94K
-96.12%31.56K
-96.12%31.56K
Free cash from
86.80%-11.07K
60.49%-189.29K
61.39%-183.07K
42.33%-991.25K
-15.26%45.91K
93.71%-83.83K
-323.22%-479.13K
-45.20%-474.2K
-4.27%-1.72M
111.80%54.18K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Aug 31, 2024(Q2)May 31, 2024(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 86.80%-11.07K60.49%-189.29K61.39%-183.07K42.33%-991.25K125.17%45.91K92.37%-83.83K-323.22%-479.13K-46.31%-474.2K-4.27%-1.72M60.29%-182.39K
Net income from continuing operations -193.05%-357.39K9.51%-562.4K11.97%-328.95K20.21%-1.4M50.88%-282.33K71.48%-121.96K-23.28%-621.49K-51.08%-373.69K14.51%-1.75M-11.00%-574.78K
Operating gains losses ---1.24K--6.11K--1.25K-119.92%-1.24K------------------6.21K----
Depreciation and amortization -28.15%393-28.21%392-28.02%393-76.28%2.19K-92.23%546-24.76%547-24.90%546-24.90%54611.98%9.21K-14.54%7.03K
Asset impairment expenditure --------------48.61K------------------0----
Remuneration paid in stock 184.22%22.88K7.80%239.55K367.25%125.07K12.90%234.03K-87.39%12.22K-124.60%-27.16K--222.21K--26.77K-71.90%207.29K589.95%96.89K
Other non cashItems -----------1-74.21%14.48K--14.48K--------------56.15K----
Change In working capital 299.91%324.29K231.33%127.05K114.99%19.17K145.19%110.15K12.17%253.63K110.36%81.09K-124.79%-96.75K-64.97%-127.82K28.87%-243.73K222.55%226.11K
-Change in receivables -159.10%-10.47K-43.12%-9.16K228.36%18.08K-168.26%-12.05K-1,108.36%-9.29K-44.27%17.72K26.13%-6.4K-120.13%-14.08K161.14%17.65K111.01%921
-Change in inventory --0--0--0--0--0--0--0--0-463.10%-610----
-Change in prepaid assets 494.81%45.98K-4.55%46.33K-4,816.94%-131.18K174.84%51.12K-60.24%16.9K90.13%-11.65K5,004.21%48.54K-142.46%-2.67K-195.72%-68.31K187.49%42.5K
-Change in payables and accrued expense 284.94%288.78K164.71%89.88K219.09%132.27K136.93%71.08K34.21%246.02K110.77%75.02K-134.90%-138.89K-43.56%-111.07K33.83%-192.46K187.29%183.3K
Cash from discontinued investing activities
Operating cash flow 86.80%-11.07K60.49%-189.29K61.39%-183.07K42.33%-991.25K125.17%45.91K92.37%-83.83K-323.22%-479.13K-46.31%-474.2K-4.27%-1.72M60.29%-182.39K
Investing cash flow
Cash flow from continuing investing activities -0.45%-54.99K15.05%-38.1K10.44%-37.55K36.27%-174.72K11.66%-33.21K15.65%-54.74K-291.95%-44.85K78.51%-41.92K37.42%-274.15K79.73%-37.59K
Net PPE purchase and sale --------------0------------------8.76K--11.24K
Net other investing changes -0.45%-54.99K15.05%-38.1K10.44%-37.55K38.24%-174.72K---33.21K---54.74K-291.95%-44.85K78.23%-41.92K35.42%-282.91K----
Cash from discontinued investing activities
Investing cash flow -0.45%-54.99K15.05%-38.1K10.44%-37.55K36.27%-174.72K11.66%-33.21K15.65%-54.74K-291.95%-44.85K78.51%-41.92K37.42%-274.15K79.73%-37.59K
Financing cash flow
Cash flow from continuing financing activities 242.00%55.92K-138.59%-9.19K-58.80%468.28K-6.19%1.14M3.88%-12.5K-98.62%16.35K-145.79%-3.85K3,760.51%1.14M-58.17%1.21M-39.06%-13.01K
Net issuance payments of debt --------------0----------------12.18%-16.56K6.29%-8.76K
Net common stock issuance -96.76%530-46.30%-5.63K-58.86%493.6K-3.70%1.2M-194.74%-12.5K-98.69%16.35K---3.85K--1.2M-45.94%1.25M---4.24K
Proceeds from stock option exercised by employees --------------0-----------------94.78%41K--0
Net other financing activities --0---3.56K60.09%-25.32K-7.54%-63.45K--0--0--0---63.45K66.47%-59K--0
Cash from discontinued financing activities
Financing cash flow 242.00%55.92K-138.61%-9.19K-58.80%468.28K-6.19%1.14M3.88%-12.5K-98.62%16.35K-145.79%-3.85K3,760.51%1.14M-58.17%1.21M-39.08%-13.01K
Net cash flow
Beginning cash position -89.39%13.17K-61.69%249.75K-93.39%2.09K-96.12%31.56K-99.29%1.88K-48.68%124.1K101.67%651.94K-96.12%31.56K27,300.30%812.97K-81.97%264.54K
Current changes in cash 91.71%-10.13K55.18%-236.58K-60.08%247.67K96.23%-29.48K100.09%203-638.30%-122.22K-548.18%-527.83K226.68%620.37K-196.47%-781.41K64.38%-232.98K
End cash Position 61.26%3.04K-89.39%13.17K-61.69%249.75K-93.39%2.09K-93.39%2.09K-99.29%1.88K-48.68%124.1K101.67%651.94K-96.12%31.56K-96.12%31.56K
Free cash from 86.80%-11.07K60.49%-189.29K61.39%-183.07K42.33%-991.25K-15.26%45.91K93.71%-83.83K-323.22%-479.13K-45.20%-474.2K-4.27%-1.72M111.80%54.18K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data